116
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Serum Levels of Cytokines and Soluble Cytokine Receptors in Patients with Metastatic Renal Cell Carcinoma or Malignant Melanoma Receiving IL-2/Interferon-α Combination Therapy

, , &
Pages 599-603 | Received 03 Oct 1994, Accepted 14 Mar 1995, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rafael Fernandez-Botran. (1999) Soluble Cytokine Receptors: Basic Immunology and Clinical Applications. Critical Reviews in Clinical Laboratory Sciences 36:3, pages 165-224.
Read now

Articles from other publishers (11)

P. Pellegrini, I. Contasta, A. M. Berghella, T. Del Beato & D. Adorno. 2010. Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy, and Prognosis 194 213 .
Anna Maria BerghellaIda ContastaPatrizia PellegriniTiziana Del BeatoDomenico Adorno. (2006) Are Immunological Mechanisms Involved in Colon Cancer and Are They Possible Markers for Biotherapy Improvement?. Cancer Biotherapy and Radiopharmaceuticals 21:5, pages 468-487.
Crossref
Patrizia PellegriniAnna Maria BerghellaIda ContastaTiziana Del BeatoDomenico Adorno. (2006) The Study of a Patient's Immune System May Prove to be a Useful Noninvasive Tool for Stage Classification in Colon Cancer. Cancer Biotherapy and Radiopharmaceuticals 21:5, pages 443-467.
Crossref
Patrizia Pellegrini, Rocco Totaro, Ida Contasta, Anna Maria Berghella, Tomassina Russo, Antonio Carolei & Domenico Adorno. (2004) IFN??-1a Treatment and Reestablishment of Th1 Regulation in MS Patients. Clinical Neuropharmacology 27:6, pages 258-269.
Crossref
Gary Brewer, Simona Saccani, Srijata Sarkar, Anita Lewis & Sidney Pestka. (2003) Increased Interleukin-10 mRNA Stability in Melanoma Cells Is Associated with Decreased Levels of A + U-Rich Element Binding Factor AUF1. Journal of Interferon & Cytokine Research 23:10, pages 553-564.
Crossref
Helen Gogas, George Paterakis, Konstantina Frangia, Dimitrios Bafaloukos, Dimitrios Pectasides, Haralambos P. Kalofonos, Dimitrios Loukopoulos, Cathrin Stavropoulou-Giokas, John Ioannovich & Martin C. MihmJr.Jr.. (2002) Lymphocyte Subpopulations and Interleukin Levels in High-Risk Melanoma Patients Treated With High-Dose Interferon A-2B. American Journal of Clinical Oncology 25:6, pages 591-596.
Crossref
Giuseppe Sconocchia, Nella Y. Cococcetta, Laura Campagnano, Sergio Amadori, Beniamino Iorio, Vittorio Boffo, Vincenzo Ferdinandi, Ilaria Del Principe, Domenico Adorno & Carlo U. Casciani. (2001) Subcutaneous Administration of Interleukin-2 Triggers Fcγ Receptor I Expression on Human Peripheral Blood Neutrophils in Solid and Hematologic Malignancies. Journal of Immunotherapy 24:4, pages 374-383.
Crossref
Sergei V. Kotenko, Simona Saccani, Lara S. Izotova, Olga V. Mirochnitchenko & Sidney Pestka. (2000) Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proceedings of the National Academy of Sciences 97:4, pages 1695-1700.
Crossref
Gottfried J. Locker, Stylianos Kapiotis, Marvio Veitl, Robert M. Mader, Brigitte Stoiser, Julia Kofler, Anna E. Sieder, Hugo Rainer, Günther G. Steger, Christine Mannhalter & Oswald F. Wagner. (2005) Activation of endothelium by immunotherapy with interleukin‐2 in patients with malignant disorders. British Journal of Haematology 105:4, pages 912-919.
Crossref
Kugler, Seseke, Thelen, Kallerhoff, MÜller, Stuhler, MÜller & Ringert. (2002) Autologous and allogenic hybrid cell vaccine in patients with metastatic renal cell carcinoma. British Journal of Urology 82:4, pages 487-493.
Crossref
Tiziana Del Beato, Anna Maria Berghella, Patrizia Pellegrini, Adorno Domenico & Carlo Umberto Casciani. (1997) The Role of the Soluble CD30 Serum Level in Colorectal Cancer: A Possible Marker for a Patient Subset Which Could Benefit from IL-2 Biotherapy. Cancer Biotherapy and Radiopharmaceuticals 12:5, pages 297-304.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.